AzTrials
AzTrials

AmputationNCT06214026

Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis

A study testing META-Arc foot locked and META-Arc foot unlocked in people with Amputation, run by University of Washington at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

People with lower extremity amputation (LEA) have persistent problems with balance, falls, residual limb pain, functional mobility, cognitive attention during gait, and satisfaction with participation in daily activities, despite using prostheses. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Amputation
What is being tested?
META-Arc foot locked and META-Arc foot unlocked
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
3 sitesUnited States
Study dates
1 Sep 2023to Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Participants will be 16-years or older, regardless of gender, race, or ethnicity.
  • Potential participants should reside in the community or an independent living environment.
  • The upper weight limit is 165.6 kg (365 lbs.).
  • Prosthetic foot sizes 22 cm (approximate US Men's shoe size 5) up to 30 cm (13 US Men's).
  • Ability to walk more than 400 m on level ground without an increase in pain.
  • At least one year post-amputation and using a prosthesis
  • People must have the ability to read, write, and comprehend English.

Who cannot join

  • Participants must not have conditions such as skin wounds that preclude the use of a prosthesis.
  • People will be excluded if they have fluctuating conditions that may significantly alter gait mechanics during the ~10-week study. Examples include Parkinson's disease, alcoholism, brain tumor, and hereditary cerebellar ataxias.
  • Participants may use a walking aid but should not primarily rely on wheelchair mobility.
  • People will be discontinued from the study if they become unable to use a prosthesis. Examples include major surgery and trauma. However, because of the potential for fluctuations in prosthesis use with this population, short-term issues will not disqualify people from continued participation when they resume prosthetic use.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States3 sites, 3 recruiting
  • WillowWood Global

    Mount Sterling, Ohio, 43143

    Alex Arbury, CPO, 740-869-3377 ext. 213, alex.albury@willowwood.com

    Jim Colvin, 740-869-3377 ext. 131, jim.colvin@willowwood.com

    Recruiting
  • University of Washington

    Seattle, Washington, 98195

    Monica Smersh, 425-331-9737, msmersh@uw.edu

    Murray Maitland, PhD, 4252865278, mmaitlan@u.washington.edu

    Recruiting
  • University of South Florida

    Tampa, Florida, 333620

    Stephanie Carey, PhD, 813-974-5765, scarey3@usf.edu

    Recruiting

Other trials in United States

About this study

Official title: The Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis for People With Above-Knee Amputations, Bilateral Amputations, or Limited Mobility

People with lower extremity amputation (LEA) have persistent problems with balance, falls, residual limb pain, functional mobility, cognitive attention during gait, and satisfaction with participation in daily activities, despite using prostheses. The purpose of this randomized clinical trial is to advance understanding of how dynamic foot design features may help people with LEA This study will include people with above-knee amputations, or with bilateral amputations, or with below-knee amputations and lower levels of mobility.

The main study questions/goals are:

Read more

1a) To determine if frontal plane adaptation in a foot prosthesis impacts performance, comfort, activities of daily living, and community mobility in the study populations. To answer this question, we will compare a locked and unlocked version of the novel prosthesis.

1b) To determine how the unlocked investigational foot condition compares to the person's usual foot using the outcomes listed above.

  1. To examine the participants' lived experience during community activities. The study will use performance tests, questionnaires, logbooks, and interviews to monitor person-centered outcomes and perceptions of personal functioning during the use of the investigational foot (locked and unlocked) compared to the person's usual foot.
Read the detailed description

The study design is a randomized cross-over clinical trial design (B1 and B2 phases) comparing a carbon fiber foot that includes a functional, unlocked frontal plane adaptable linkage compared to the same foot with the linkage locked to prevent frontal plane motion. With the linkage locked, the foot is comparable to energy storage and return of a carbon fiber foot. The secondary aim for this clinical trial compares the unlocked foot to the participant's usual foot (A1 and A2 phases), representative of the usual standard of care.

The testing will be conducted following an A1-B1-B2-A2 design. The A conditions are focused on the participant's usual prosthetic foot. The B conditions are focused on locked and unlocked frontal plane adaptable linkages with the order randomized. Block randomization, stratified by study site, will be used to determine the order participants receive the locked and unlocked prosthetic. In our recent clinical trial, we developed a simple pin system to prevent the linkage from rotating.

A1 represents Visit 1, where demographic data are entered. As well, baseline questionnaires and performance data are collected. The participant will become familiar with the online data gathering systems. Then, the participant will be fitted with the adaptable foot by a licensed prosthetist. The linkage will be either locked or unlocked depending on the randomization. People with bilateral amputations will receive symmetrical prostheses.

During the ~2-week B1 phase, the participant will perform their normal community activities and contribute usage data, performance ratings, and qualitative data via the online logbook. There is the possibility that the decision may be made to re-fit the participant with a different stiffness of the study foot/feet that will be better suited. If this happens, the at-home use period of participation will be extended for another 2- to 4 weeks. At the end of the B1 phase, participants will complete standardized questionnaires and performance tests at Visit 2. Then, the linkage will be either locked or unlocked depending on the B1 randomization.

The ~2-week B2 phase will allow the participant to continue community activities and complete online logbooks. At the finish of the B2 phase, questionnaires and performance tests will be completed at Visit 3. A semi-structured interview will occur to compare the locked and unlocked versions.

The purpose of the second ~2-week A2 phase is for the participant to reflect on differences between the adaptable foot and the usual foot after having experiences with the adaptable linkage in the unlocked configuration. Questionnaires and an interview will occur at the final participant session, Visit 4.

Questionnaires: The demographic survey, online questionnaires, and activity logbooks will be developed in REDCap and administered either online or on paper, depending on the participant's preferences. Unique URL invitations are sent to participants via email, and reminders are sent if there is a delay in data entry. Data are collected in a database format for analysis.

Demographic questions cover age, gender, date of amputation, number of prosthetic feet, description of the usual foot (feet), walking aids, overall health rating, fall history, occupation (if working), physical activity, comorbidities, amputation etiology, veteran status, employment status, education level, race, and ethnicity.

The Prosthetic Limb Users Survey of Mobility (PLUS-M™) The PLUS-M 12-item questionnaire examines the difficulty of typical everyday mobility activities on a 5-point Likert scale.

Logbooks: Participants will complete daily structured logbooks. Daily logbooks will capture information about prosthetic use (which prosthesis was worn, length of time worn), any falls, residual limb/bodily pain, and provide an opportunity to make notes about any activities that were noticeably impacted by the prosthetic foot. There will be opportunities for participants to provide information about challenging situations and social interaction using scales and open-ended questions. Participants will be encouraged to provide descriptions of activities, including strengths and limitations of foot performance, and to address ADL that might be associated with secondary conditions such as pain, poor balance, safety, fear of falling, attention to foot placement, bilateral activities, surfaces, and uneven ground. Logbooks will be developed in REDCap and can be completed online or on paper. Logbook data will inform the content of the interviews.

Semi-structured Interviews: There will be interviews after research phases B2 (innovative foot) and A2 (usual foot). These interviews will clarify significant events documented in the logbooks. The focus of interviews will be on gathering information about the participants' experience using different prosthetic feet, with an emphasis on identifying activities that are facilitated or hindered by the functioning of the prosthetic foot. Interviews will be audio recorded for transcription and analysis.

Physical performance tests Forward walking (10-meter walk test) Forward walking at a self-selected speed is a basic test of mobility and is correlated to community function. Spatiotemporal variables during this test will be measured using an instrumented Zeno Walkway.

The Timed Up and Go Test (TUG) For the TUG, the participant, starts sitting in a chair and, on the command "go," rises, walks 3 meters, turns 180 degrees, returns to the chair, and sits down. There is typically one practice and one test. This is a timed test. In addition to total time, spatiotemporal variables during the TUG will be collected using an instrumented Zeno Walkway.

The Three Times Figure of Eight Walk Test (3XF8W) The 3XF8W involves significant turning requirements for the participant. The test was developed to represent walking skills used in everyday life, involving straight and curved paths in both right and left directions. Subjects will begin the task standing between the 2 cones 1.52 m apart. The subject will walk a figure 8 course 3 times for each condition at their self-selected pace and stop when they return to the start position. The outcomes of the test are the time to complete the course and the number of steps taken.

Four-square step test (FSST) The FSST is a complex stepping sequence. The participant is instructed to "Try to complete the sequence as fast as possible without touching the sticks. Both feet must contact the floor in each square. If possible, face forward during the entire sequence." The performance tests are ordered in increasing complexity and challenge for people with lower levels of mobility. The FSST combines side-step in both directions, as well as forward and backward stepping. Spatiotemporal variables during this test will also be collected on an instrumented Zeno Walkway.

Conditions
Amputation
Being tested
META-Arc foot locked, META-Arc foot unlocked
Keywords
prosthesis, foot prosthesis, Above-knee amputation, Bilateral lower extremity amputation, mobility disability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • META-Arc foot lockedDevice

    Participants are provided with the META-Arc from WIllowWood Global, and a locking mechanism prevents side-to-side motion.

  • META-Arc foot unlockedDevice

    Participants are provided with the META-Arc from WIllowWood Global allowing side-to-side motion.

Study groups in NCT06214026
Study groupRoleWhat they receive
Locked ankle articulationExperimentalThe design is a randomized cross-over clinical trial following an A1-B1-B2-A2 design. In the locked condition, the 20 degree of frontal plane ankle motion is eliminated by a physical lock. The A conditions will be with the usual foot. The B conditions are randomized to the locked and unlocked investigational foot.
Receives: Device: META-Arc foot locked
Unlocked ankle articulationExperimentalThe design is a randomized cross-over clinical trial following an A1-B1-B2-A2 design. In the unlocked condition, the 20 degree of frontal plane ankle motion is enabled. The A conditions will be with the usual foot. The B conditions are randomized to the locked and unlocked investigational foot.
Receives: Device: META-Arc foot unlocked

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 10-Meter Walk Test

    Forward walking for 10 meters at a self-selected speed.

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  2. Timed Up and Go Test

    The Timed Up and Go Test starts with participant sitting in a chair. On the command "go," the individual will get up and walk 3 meters, turn 180 degrees to walk back the way they came, return to the chair, and sit down. There is one practice and one test.

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  3. Figure-of-8 Walk Test

    For the Figure-of-8 Walk Test the participant will walk at their own pace three times in a figure-of-8 pattern around two cones placed 5 feet apart. They will have the opportunity to practice, and then the test will be repeated three times.

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  4. The Four-square Step Test (FSST)

    The Four-square Step Test (FSST) involves stepping sideways, backwards, and forward following a pattern.

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  5. The Prosthetic Limb Users Survey of Mobility (PLUS-M™)

    The PLUS-M 12-item questionnaire examines typical everyday mobility activities on a 5-point Likert scale.

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

Secondary outcomes (4)
  1. Spatiotemporal parameters of gait

    Degree of asymmetry: Percent difference

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  2. Spatiotemporal parameters of gait

    Step width: meters

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  3. Spatiotemporal parameters of gait

    Step length: meters

    Measured: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).

  4. Daily Activity Logbook: Balance Confidence

    Self-reported confidence in balance on a 0-100 scale (higher scores indicate greater confidence).

    Measured: Average of daily logbook across the 2-week trial of each investigational foot condition.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jan 2024
  2. Study start1 Sep 2023
  3. Primary completionSep 2026 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
A1, B1, B2, A2 crossover design
Masking
None (open label)
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06214026
Sponsor's protocol ID
STUDY00017239
Other IDs
OP220033
Status last verified
May 2024
First submitted
20 Nov 2023
Last updated
23 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes

Publications

  • Carey SL, Highsmith MJ, Farrag S, Gries MC, Allyn KJ, Humbert AT, Fogelberg DJ, Colvin JM, Wernke MM, Maitland ME. The Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis: Protocol for a Randomized Crossover Clinical Trial. JMIR Res Protoc. 2025 Dec 23;14:e84313. doi: 10.2196/84313.

    PubMed 41432542

Questions about this trial

What is this clinical trial studying?

A study testing META-Arc foot locked and META-Arc foot unlocked in people with Amputation, run by University of Washington at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Monica Smersh (206-543-6995, msmersh@u.washington.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

10-Meter Walk Test (time frame: After 2-week trial of investigational foot Condition 1 (B1), after 2-week trial of investigational foot Condition 2 (B2) after return to usual foot for 2 weeks (A2).). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06214026, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in